Brief: Mabpharm Says Wang Hao Appointed As CEO
28/10/2020 11:53
Oct 28 (Reuters) - Mabpharm Ltd 2181.HK :
* WANG HAO HAS BEEN APPOINTED AS CHIEF EXECUTIVE OFFICER
* TAO JING HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR
* QIAN WEIZHU HAS RESIGNED AS AN EXECUTIVE DIRECTOR, CHIEF
EXECUTIVE OFFICER
Source text https://bit.ly/3kC1eja
Further company coverage: 2181.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mabpharm
See all newsBrief: Mabpharm Says NMPA Approves CMAB807X (Denosumab Injection) NDA
Brief: Mabpharm Says NMPA Approves Cmab807 (Denosumab Injection) NDA
Brief: Mabpharm FY Profit And Total Comprehensive Income Attributable Rmb57.1 Million
Brief: Mabpharm Says Approval From Drug Regulatory Authority Of Pakistan On Registration Of Core Product,CMAB008
Brief: Mabpharm Says Approval From Indonesian National Agency Of Drug And Food Control Of CMAB008